The approved product is bioequivalent to the reference listed drug product (RLD), Ritalin LA extended-release capsules of Novartis Pharmaceuticals Corporation.
from Latest News http://bit.ly/2HG251j
Monday, 27 May 2019
Granules India receives final approval for ADHD treatment drug from USFDA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment